Palatin Technologies (PTNT) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock PTNT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Four new option listings and two option delistings on August 12thAugust 14 at 11:50 AM | msn.comPalatin Technologies, Inc.: Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of ObesityJuly 15, 2025 | finanznachrichten.dePalatin Technologies, Inc. (AMEX:PTN) Q3 2025 Earnings Call TranscriptMay 20, 2025 | insidermonkey.comPalatin Technologies, Inc. (PTN) Q3 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comPalatin Technologies Inc (PTNT) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...May 15, 2025 | gurufocus.comQ3 2025 Palatin Technologies Inc Earnings Call TranscriptMay 14, 2025 | gurufocus.comPTNT Palatin Technologies, Inc.May 12, 2025 | seekingalpha.comPalatin Expects $11.5 Mln Offering To Aid NYSE Compliance And Fuel Obesity Drug DevelopmentMay 9, 2025 | nasdaq.comPalatin presents preclinical data on PL9654 and PL9655 at ARVOMay 9, 2025 | msn.comPalatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025May 9, 2025 | prnewswire.comPalatin Technologies Announces Encouraging Pre-Clinical Data Of PL9588 For Glaucoma TreatmentMay 7, 2025 | nasdaq.comPalatin Technologies faces delisting from NYSE American due to low stock priceMay 7, 2025 | in.investing.comPalatin Technologies faces delisting from NYSE American due to low stock priceMay 7, 2025 | in.investing.comNYSE American to Commence Delisting Proceedings Against Palatin Technologies, Inc. (PTN)May 7, 2025 | businesswire.comPalatin Expects $11.5 Million Financing to Cure NYSE American Delisting NoticeMay 7, 2025 | prnewswire.comPalatin Technologies Announces Pricing of up to $23 Million Public OfferingMay 7, 2025 | prnewswire.comPalatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma TherapyMay 5, 2025 | prnewswire.comPL9643 shows promise in dry eye disease treatmentApril 30, 2025 | investing.comPalatin Reports Positive Results From Responder Analyses Of Phase 3 MELODY-1 Study In DEDApril 30, 2025 | nasdaq.comPalatin Announces Breakthrough Symptom Resolution in Updated Analyses from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye DiseaseApril 29, 2025 | prnewswire.comPalatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and TirzepatideApril 17, 2025 | prnewswire.comPalatin Appeals NYSE American Notice of DelistingApril 14, 2025 | prnewswire.comPalatin receives NYSE American notice of delisting, plans to appealApril 11, 2025 | markets.businessinsider.comPalatin Technologies Reports Positive Data From Phase 2b BREAKOUT StudyApril 11, 2025 | nasdaq.comNYSE American to Commence Delisting Proceedings Against Palatin Technologies, Inc. (PTN)April 10, 2025 | tmcnet.comPalatin Technologies, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to AppealApril 10, 2025 | finance.yahoo.comPalatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring MeetingApril 10, 2025 | prnewswire.comPalatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring MeetingApril 10, 2025 | prnewswire.comPalatin: Bremelanotide-Tirzepatide Combination Achieves Primary Endpoint In Phase 2 Obesity StudyApril 2, 2025 | nasdaq.comPalatin says BMT-801 Phase 2 obesity study met primary endpointApril 1, 2025 | markets.businessinsider.comPalatin files to sell 17.32M shares of common stock, warrantsApril 1, 2025 | markets.businessinsider.comPalatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity StudyMarch 31, 2025 | prnewswire.comPalatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177March 28, 2025 | prnewswire.comPalatin Technologies, Inc.: Palatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor DeficiencyMarch 25, 2025 | finanznachrichten.dePalatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor DeficiencyMarch 25, 2025 | prnewswire.comHere's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock NowMarch 13, 2025 | msn.comPalatin Technologies, Inc. (PTN) Q2 2025 Earnings Call TranscriptFebruary 15, 2025 | seekingalpha.comPalatin Technologies, Inc. (AMEX:PTN) Q2 2025 Earnings Call TranscriptFebruary 14, 2025 | insidermonkey.comQ2 2025 Palatin Technologies Inc Earnings CallFebruary 14, 2025 | uk.finance.yahoo.comPalatin Technologies, Inc.: Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business UpdateFebruary 13, 2025 | finanznachrichten.dePalatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business UpdateFebruary 13, 2025 | prnewswire.comPalatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025February 10, 2025 | prnewswire.comPalatin Gains on New OfferingFebruary 8, 2025 | baystreet.caPalatin Technologies Announces $4.7 Mln Direct OfferingFebruary 8, 2025 | markets.businessinsider.comPalatin secures $4.7 million in stock and warrant saleFebruary 8, 2025 | msn.comPalatin Announces $4.7 Million Registered Direct Offering and Concurrent Private PlacementFebruary 7, 2025 | prnewswire.comPalatin Technologies, Inc.: Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP TirzepatideFebruary 6, 2025 | finanznachrichten.dePalatin finishes phase 2 trial in obesity treatment studyFebruary 6, 2025 | msn.comPalatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP TirzepatideFebruary 6, 2025 | prnewswire.comPalatin gears up for obesity treatment trials in 2025January 28, 2025 | msn.com Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTNT and its competitors with MarketBeat's FREE daily newsletter. Email Address PTNT Media Mentions By Week PTNT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTNT News Sentiment▼-1.000.61▲Average Medical News Sentiment PTNT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTNT Articles This Week▼31▲PTNT Articles Average Week Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTNT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCDA News IBIO News PRTG News SNSE News BFRI News SNGX News APRE News DWTX News RNAZ News ADXN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (PINK:PTNT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palatin Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access